Compare CLOV & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLOV | POET |
|---|---|---|
| Founded | 2014 | 1972 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2020 | 2008 |
| Metric | CLOV | POET |
|---|---|---|
| Price | $4.69 | $8.84 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $2.90 | N/A |
| AVG Volume (30 Days) | 8.9M | ★ 19.9M |
| Earning Date | 05-06-2026 | 08-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.03 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $1,924,308,000.00 | N/A |
| Revenue This Year | $52.59 | $848.96 |
| Revenue Next Year | $15.37 | $700.00 |
| P/E Ratio | $93.20 | ★ N/A |
| Revenue Growth | ★ 40.34 | N/A |
| 52 Week Low | $1.58 | $3.87 |
| 52 Week High | $5.59 | $20.65 |
| Indicator | CLOV | POET |
|---|---|---|
| Relative Strength Index (RSI) | 49.91 | 40.22 |
| Support Level | $1.96 | $6.42 |
| Resistance Level | $5.18 | $9.14 |
| Average True Range (ATR) | 0.28 | 0.92 |
| MACD | -0.12 | -0.25 |
| Stochastic Oscillator | 5.73 | 16.94 |
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.